India builds on success
- Pharma firms tap jobless pool for new talent. MOONEY, BILL // njbiz;7/19/2010, Vol. 23 Issue 29, p5
The article discusses how the recession allowed New Jersey's pharmaceutical industry to tap skilled labor that were laid off during company downsizing and mergers thereby creating a more competitive environment in terms of pricing structures of salaries and benefits where personnel compete to...
- Automation works. Aldridge, Susan // Pharmaceutical Technology Europe;Mar2008, Vol. 20 Issue 3, p13
The article discusses the advantages of automation for pharmaceutical and biotechnology industries and the challenges it poses for future improvements. It states that replacing manual operations with automation offers benefits for firms including increased productivity, higher quality, improved...
- Steps to Functional Service Provider Success. Lucas, Kristin M. // Applied Clinical Trials;Aug2008, Vol. 17 Issue 8, p50
The article focuses on the outsourcing clinical trials that has became a standard practice in the biotech and pharmaceutical industries as companies attempt to make greater efficiencies while reducing costs, resources, and timelines. Moreover, it says that as industry's outsourcing experience...
- Outsourcing: Boon or Curse? Koppal, Tanuja // Drug Discovery & Development;Jun2005, Vol. 8 Issue 6, p11
The article debates whether outsourcing is a boon or a curse for the American pharmaceutical industry. According to the author, outsourcing has been practiced for decades. Industries such as retail, automotive, and others have used the specialized services of contract organizations to drive down...
- Find out about new technologies to improve efficiencies. // Caribbean Business;6/18/2009, Vol. 37 Issue 24, p32
The article reports on the new technologies adopted by Communications Engineering Inc. that can help improve the efficiency of the pharmaceutical industry in Puerto Rico. Daniel La Luz Polanco, Communications President, highlights the Mototrbo, a new concept in two-way radios that uses...
- Common Mistakes in Cost-Effectiveness Analysis. Lee, A. James // Pharmaceutical Executive;Feb99, Vol. 19 Issue 2, p78
Discusses five common mistakes in pharmaceutical cost-effectiveness analysis. Human capital approach; Unsubstantiated assumptions; Missing data; Inappropriate comparisons.
- Expert Judgement in Pharmacoeconomic Studies: Guidance and Future Use. Evans, C.; Crawford, B. // PharmacoEconomics;2000, Vol. 17 Issue 6, p545
Research in the field of pharmacoeconomics has increased substantially during the past decade. Much of this research has been on the design and analysis of data concerning the relative merits of one drug or device compared with another in terms of costs and effects. Concomitant with these...
- Irish cost-effectiveness threshold too high? // PharmacoEconomics & Outcomes News;Nov2015, Vol. 740 Issue 1, p6
The article discusses an agreement between the Great Britain government and the pharmaceutical industry in which Irish cost-effectiveness threshold was set at 45,000 euro per Qaly in 2012.
- What's all this about pharmacoeconomics? Willke, Richard J. // Business Economics;Apr95, Vol. 30 Issue 2, p26
Provides an overview of the methodology and application of pharmacoeconomics. Evaluation of the cost effectiveness of medications; Aid in the allocation of health care resources; Cost benefit analysis of pharmacoeconomics.